Katja Zerbe
Impact in
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
- Pharmacogenetics and Drug Metabolism
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in
-
- Chemical Synthesis and Analysis 9
- RNA and protein synthesis mechanisms 7
- Cancer therapeutics and mechanisms 5
- Pharmacology 17
- Microbial Natural Products and Biosynthesis 17
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- John A. Robinson (20 shared papers)Francesca Vitali (6 shared papers)Katharina Woithe (6 shared papers)Dong Bo Li (5 shared papers)Kerstin Moehle (5 shared papers)Laurent Bigler (3 shared papers)Leo Eberl (4 shared papers)Olena Pylypenko (2 shared papers)
- Journals
- Journal of Biological Chemistry (3 papers)Angewandte Chemie International Edition (3 papers)Organic & Biomolecular Chemistry (2 papers)Journal of Biotechnology (1 paper)ChemBioChem (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Katja Zerbe
24 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 64
- Pharmacology 605
- Molecular Medicine 185
- Pharmacology 203
- Microbiology 144
- Molecular Biology 751
Countries citing papers authored by Katja Zerbe
This map shows the geographic impact of Katja Zerbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katja Zerbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katja Zerbe more than expected).
Fields of papers citing papers by Katja Zerbe
This network shows the impact of papers produced by Katja Zerbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katja Zerbe. The network helps show where Katja Zerbe may publish in the future.
Co-authors
The 25 scholars most cited alongside Katja Zerbe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 134 | |
| 2 | 2018 | 130 | |
| 3 | 2007 | 117 | |
| 4 | 2004 | 114 | |
| 5 | 2015 | 90 | |
| 6 | 2012 | 86 | |
| 7 | 2018 | 78 | |
| 8 | 2003 | 77 | |
| 9 | 2006 | 71 | |
| 10 | 2014 | 37 | |
| 11 | 2017 | 36 | |
| 12 | 2007 | 34 | |
| 13 | 2012 | 30 | |
| 14 | 2008 | 29 | |
| 15 | 2018 | 25 | |
| 16 | 2003 | 23 | |
| 17 | 2004 | 22 | |
| 18 | 2020 | 18 | |
| 19 | 2018 | 9 | |
| 20 | 2020 | 9 |
About Katja Zerbe
Katja Zerbe is a scholar working on Molecular Biology, Pharmacology, Genetics, Organic Chemistry and Molecular Medicine, having authored 24 papers that have together received 1.2k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (17 papers), Chemical Synthesis and Analysis (9 papers), RNA and protein synthesis mechanisms (7 papers), Cancer therapeutics and mechanisms (5 papers), Bacterial Genetics and Biotechnology (5 papers), Antibiotic Resistance in Bacteria (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Antimicrobial Peptides and Activities (3 papers). The work is most often cited by research in Pharmacology (605 citations), Molecular Medicine (185 citations), Pharmacology (203 citations), Microbiology (144 citations) and Molecular Biology (751 citations). Katja Zerbe has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include John A. Robinson, Francesca Vitali, Katharina Woithe, Dong Bo Li, Kerstin Moehle, Laurent Bigler, Leo Eberl, Olena Pylypenko, Ilme Schlichting and Gabriella Pessi. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition, Organic & Biomolecular Chemistry, Journal of Biotechnology and ChemBioChem.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.